BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

MiraiBio, Inc. Launches DNASIS MAX Version 2.5 Sequence Analysis Software For Advanced Data Management


10/19/2005 5:10:38 PM

BOSTON, March 31 /PRNewswire/ -- At the BioIT World Conference & Expo, MiraiBio Inc., today introduced DNASIS(R) MAX Version 2.5 Sequence Analysis Software, their next generation desktop bioinformatics tool offering advanced data management and analysis capabilities.

DNASIS(R) MAX is a robust sequence analysis software package that delivers industry standard functionality -- molecular biology tools, multiple consensus calling methods, and rapid BLAST searches -- as well as unique features that enhance common task performance and allow user-defined product customization.

"With the release of DNASIS(R) MAX Version 2.5, MiraiBio is doing what it does best -- taking advantage of its core competencies in computer technology and software design to deliver a sophisticated and powerful bioinformatics tool to researchers all over the world," commented Masakazu Kuji, Chief Executive Officer. "We are particularly pleased with the refinement of user- customization and overall research-facilitation features that are so prominently evident in this new version."

Notable functionality additions to DNASIS MAX Version 2.5 include customizable analyses and workflows using the product's unique open application programming interface (API) and software developer's kit (SDK) and direct interface with DNASIS Gene Index, the company's data query and knowledge mining service. Additional improved and enhanced product features include drag and drop analysis with instructional "wizard," improved tandem repeat, hairpin loop, tacking site search capabilities, and increased database functionality with novel text searching and editing options.

About MiraiBio:

MiraiBio is the culmination of 12 years of imaging, spectroscopy and microarray experience in the life science industry. Providing innovatively integrated system solutions, MiraiBio enables Genomic and Proteomic research in drug discovery, basic research, and forensics. Closely working with life science researchers and technicians, the company's core mission is to deliver solutions that do far more than follow technology trends; that put tomorrow's research tools into the laboratory today. Please visit our Web site at: http://www.miraibio.com/.

Media Contact: MiraiBio 510-337-2005 Tateo Nagai Title: Manager Bioinformatics Email: tnagai@miraibio.com

MiraiBio Inc.

CONTACT: Tateo Nagai, Manager Bioinformatics of MiraiBio,+1-510-337-2005, or tnagai@miraibio.com


Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->